3rd Annual Pre-Filled Syringes Summit

28/09/2017 - 29/09/2017 Hotel SB Diagonal Zero Plaça Llevant, s/n, 08019 Barcelona, Spain

Our summit provides the appropriate platform for industry leaders to discuss best practices as well as new developments in Pre-Filled Syringes (PFS). The Summit will provide a broad overview of market trends and device needs; technologies and innovations; delivery aspects of parenteral drugs; as well as regulatory updates.

We will discuss the benefits of PFS and injection devices as the main factor for convenient dosage and safe treatment for patients.

Key Practical Learning Points of the Summit:

  • Current market developments, trends, and needs for Pre-Filled Syringes (PFS)
  • Regulatory challenges and market approval
  • Next generation design and materials for PFS
  • Combination products and auto injectors
  • Sterile manufacturing
  • Ensuring efficient drug development
  • Human-factors engineering and usability
  • Patient-centric design

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Senior Managers, Principal Scientists, Chemists, and Engineers specialising in:

  • Bioprocess Research and Development
  • Business Development
  • CMC
  • Combination Products
  • Container Development
  • Controls and Robotics
  • Device Development & Manufacturing
  • Device Engineering & Design
  • Drug Delivery & Devices
  • Drug Development
  • Drug Packaging
  • External Supply
  • Extractables & Leachables
  • Fill/Finish
  • Formulation Sciences
  • Human Factors
  • Injectables
  • Materials Development
  • Medical & Connected Devices
  • Parenterals
  • PFS
  • QA/QC
  • Regulatory Affairs
  • Research and Development
  • Risk Management
  • Stability
  • Standardisation science
  • Sterile Products
  • Vaccines
  • Validation

Featured Speakers: 

  • Mike Wallenstein, CH, Executive Director QA/Senior Compliance Officer & Head Novartis DCP Expert Network, Novartis International AG
  • Ian Thompson, CH, Vice President Business Development, Delivery Systems, Ypsomed AG
  • Stephen A. Barat, USA, Preclinical and Early Clinical Development, Scynexis, Inc
  • Andreas Kerschbaumer, AU, Deputy Head of Operational Manufacturing, Sandoz GmbH
  • Didier Pertuy, FR, VP, Global Head Drug-Device Integrated Development & Device Strategy,
  • Chris Muenzer, CH, Senior Device Engineer, Roche
  • Klaus Ullherr, GE, Senior Product Manager, Robert Bosch Packaging Technology GmbH
  • Cedric Gysel, CH, Device Engineer and Technical Product Owner, Janssen
  • Mark A. Chipperfield, UK, Company Director & Principal Consultant, Corvus Device Consultancy
  • Daniela Janek, GE, Associate Director Primary Packaging & Process Development Parenterals, Boehringer Ingelheim Pharma GmbH & Co. KG
  • Nicolas Brandes, GE, Director Market Development, EU/Asia, West Pharmaceutical
  • Bastiaan De Leeuw, UK, Strategic Marketing Director, Bespak Europe Ltd
  • Nicholas Stones, CH, Senior Device Manager – Human Factors Biologics Technical Development & Manufacturing, Novartis Pharma AG
  • Dr. Daniel Latham, CH, Head of Device Development Operations Device Development and Commercialisation – BTDM, Novartis Pharma AG